Standard

Metformin as a Metabolic Adjuvant to Amoxicillin: A Hypothesis on Synergistic Antibacterial Action. / Akl, Maher Monir; Ahmed, Amr.

в: Advanced Pharmaceutical Bulletin, Том 15, № 3, 2025, стр. 477-478.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Akl, MM & Ahmed, A 2025, 'Metformin as a Metabolic Adjuvant to Amoxicillin: A Hypothesis on Synergistic Antibacterial Action', Advanced Pharmaceutical Bulletin, Том. 15, № 3, стр. 477-478. https://doi.org/10.34172/apb.025.43917

APA

Vancouver

Akl MM, Ahmed A. Metformin as a Metabolic Adjuvant to Amoxicillin: A Hypothesis on Synergistic Antibacterial Action. Advanced Pharmaceutical Bulletin. 2025;15(3):477-478. doi: 10.34172/apb.025.43917

Author

Akl, Maher Monir ; Ahmed, Amr. / Metformin as a Metabolic Adjuvant to Amoxicillin: A Hypothesis on Synergistic Antibacterial Action. в: Advanced Pharmaceutical Bulletin. 2025 ; Том 15, № 3. стр. 477-478.

BibTeX

@article{8fdc4569fe5c4aa8b9549973581538d8,
title = "Metformin as a Metabolic Adjuvant to Amoxicillin: A Hypothesis on Synergistic Antibacterial Action",
author = "Akl, {Maher Monir} and Amr Ahmed",
note = "Akl M. M., Ahmed A. Metformin as a Metabolic Adjuvant to Amoxicillin: A Hypothesis on Synergistic Antibacterial Action / M. M. Akl, A. Ahmed // Advanced Pharmaceutical Bulletin. - 2025. - Т. 15. № 3. - С. 477-478. DOI 10.34172/apb.025.43917",
year = "2025",
doi = "10.34172/apb.025.43917",
language = "English",
volume = "15",
pages = "477--478",
journal = "Advanced Pharmaceutical Bulletin",
issn = "2228-5881",
publisher = "Tabriz University of Medical Sciences",
number = "3",

}

RIS

TY - JOUR

T1 - Metformin as a Metabolic Adjuvant to Amoxicillin: A Hypothesis on Synergistic Antibacterial Action

AU - Akl, Maher Monir

AU - Ahmed, Amr

N1 - Akl M. M., Ahmed A. Metformin as a Metabolic Adjuvant to Amoxicillin: A Hypothesis on Synergistic Antibacterial Action / M. M. Akl, A. Ahmed // Advanced Pharmaceutical Bulletin. - 2025. - Т. 15. № 3. - С. 477-478. DOI 10.34172/apb.025.43917

PY - 2025

Y1 - 2025

UR - https://www.mendeley.com/catalogue/c3eeefcb-2fd0-3333-ae2b-1d280f6eaff4/

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105020307789&origin=inward

U2 - 10.34172/apb.025.43917

DO - 10.34172/apb.025.43917

M3 - Article

VL - 15

SP - 477

EP - 478

JO - Advanced Pharmaceutical Bulletin

JF - Advanced Pharmaceutical Bulletin

SN - 2228-5881

IS - 3

ER -

ID: 71809131